Spermidine vs Fisetin: Two Longevity Supplements, Honestly Compared

Spermidine and fisetin land on the same shortlist of buzzy longevity supplements, so people naturally ask which one to pick. That framing is slightly wrong from the start: these two molecules do completely different things to aging cells, sit on different parts of the evidence map, and aren't really competing for the same slot in a stack. This page puts them side by side honestly — what each is supposed to do, how strong the human case actually is for each, and who, realistically, might consider which. We grade both individually in spermidine for longevity and fisetin as a senolytic; this is the head-to-head. For the full field, start with best longevity supplements, rated by evidence.

Two molecules, two completely different jobs

The single most important thing to understand is that spermidine and fisetin attack aging from opposite ends. Spermidine is a polyamine that your body makes and you eat; its signature action is inducing autophagy — the cell's recycling system that clears out damaged proteins and organelles, and that declines with age. The authoritative review of the field frames spermidine as a caloric-restriction mimetic working largely through this pathway¹. Fisetin is a plant flavonoid whose claim to fame is acting as a senolytic — selectively killing the worn-out "zombie" cells that stop dividing but refuse to die and instead leak inflammatory signals into surrounding tissue².

Both autophagy decline and cellular senescence are catalogued among the formal hallmarks of aging³, so both molecules have a legitimate target. But one tidies the inside of cells continuously, and the other removes bad cells entirely — which is why the dosing philosophies differ so sharply, and why thinking of them as either/or misses the point.

Where the evidence actually stands

This is where an honest comparison earns its keep, because the two have very different shapes of evidence — and neither is "proven in humans."

Spermidine has the better human footprint, but it's a mixed one. Two large prospective cohorts found that higher dietary intake tracked with lower mortality, which is a genuine population signal — though it's an association tangled up with overall diet quality, not proof. Crucially, the one adequately-powered randomized human trial (the 12-month SmartAge study in older adults with cognitive decline) was negative on its primary cognitive endpoint⁴. So spermidine's story is: clean mechanism, real epidemiology, and a flagship trial that came back null.

Fisetin has the more dramatic animal footprint and almost no human footprint. In aged mice, intermittent fisetin cleared senescent cells, reduced age-related inflammation, and extended both health and lifespan by roughly 10% — even when started late in life⁵. That's a stronger preclinical headline than spermidine's null human trial. But the encouraging human senolytic trials used a different drug combination (dasatinib plus quercetin), which measurably reduced senescent-cell burden in human tissue⁶ — not fisetin. Fisetin's own human longevity data are essentially absent, and its poor oral bioavailability raises real doubt about whether capsules even reach active levels.

So the honest scoreboard isn't "which wins" — it's that spermidine has weak-but-real human data with a disappointing trial, while fisetin has strong mouse data and near-zero human longevity data borrowing credibility from a different drug.

Dosing realities are different too

Because the mechanisms differ, so does how each is taken. Spermidine is a daily supplement — most human research used concentrated wheat-germ extract standardized to a spermidine content, taken continuously, on the logic that you're nudging an everyday housekeeping process. Fisetin follows the "hit-and-run" model borrowed from senolytic research: short, high-dose intermittent courses (often around 20 mg/kg/day for two consecutive days) rather than a daily pill, on the logic that clearing zombie cells once buys time before they re-accumulate. Those research doses are far higher than a typical off-the-shelf capsule, and whether standard products hit senolytic concentrations in people is unknown.

Both are sold as dietary supplements, not approved drugs — no required efficacy proof, no approved indication, manufacturer-controlled labels. Spermidine's safety at studied doses looks reasonable (it's a molecule you eat daily); fisetin's short trial courses appeared tolerable, but long-term high-dose intermittent self-use isn't validated for safety. "Tolerable in a small study" is not "proven safe for years of self-directed use" for either.

So who might consider which?

Because the mechanisms don't overlap, this isn't a coin flip between two interchangeable pills. If you're drawn to the molecule with the most coherent everyday mechanism and an actual human population signal — and you can accept that its best trial was null — spermidine is the more conservative, better-characterized-in-humans choice. If you're specifically interested in the senolytic idea and are comfortable acting on strong mouse data while human longevity evidence for fisetin itself remains near-zero, fisetin is the experimental bet. Quercetin, fisetin's senolytic neighbor, has the same borrowed-credibility problem and is covered in quercetin for longevity.

Neither is a proven anti-aging intervention, and nothing here is medical advice — both warrant a conversation with your clinician, especially alongside other medications. For how we weigh evidence across every option and provider, see how we grade longevity providers, and explore our longevity tools to think through your own situation.

The bottom line

Spermidine and fisetin are easy to lump together and shouldn't be. Spermidine works through autophagy, is taken daily, carries a real human mortality association, and has a negative flagship trial — weak-but-honest human evidence. Fisetin works as a senolytic, is taken intermittently, has standout mouse data, and has near-zero human longevity evidence, with the encouraging human senolytic results actually belonging to a different drug combination. Different jobs, different evidence grades, not really either/or. If you take either, take it knowing the mechanism is legitimate and the human longevity payoff is unproven — for both.